Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Price to FCF Ratio 2014–2026
Price to free cash flow (P/FCF) ratio for Crescent Biopharma, Inc. (CBIO): market cap divided by trailing twelve-month free cash flow. As of it is —.
From: 03/31/2014To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Crescent Biopharma, Inc. Price to FCF Ratio — FAQ
Crescent Biopharma, Inc. (CBIO) price to fcf ratio over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's price to fcf ratio history?
The chart and table above show Crescent Biopharma, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.